Drug Combination for liver diseases (Waterstone Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDrug Combination for liver diseases (Waterstone Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNiemann-Pick C1-like protein 1 inhibitors
TargetsNiemann-Pick C1-like protein 1
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWaterstone Pharmaceuticals (Wuhan) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWaterstone Pharmaceuticals (Wuhan) Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A